Niagen Bioscience
(NASDAQ) NAGE
Niagen Bioscience Financials at a Glance
Market Cap
$269.20M
Revenue (TTM)
$130.42M
Net Income (TTM)
$18.64M
EPS (TTM)
$0.22
P/E Ratio
15.48
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Price
$3.52
Volume
13,263
Open
$3.39
Price
$3.52
Volume
13,263
Open
$3.39
Previous Close
$3.38
Daily Range
$3.39 - $3.52
52-Week Range
$3.35 - $14.69
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Price
$3.52
Volume
13,263
Open
$3.39
Previous Close
$3.38
Daily Range
$3.39 - $3.52
52-Week Range
$3.35 - $14.69
Estimated Earnings Date
Aug 5, 2026
NAGE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Niagen Bioscience
Industry
Personal Products
Sector
Consumer StaplesEmployees
117
CEO
Robert N. Fried, MBA
Website
www.niagenbioscience.comHeadquarters
Los Angeles, CA 90024, US
NAGE Financials
Key Financial Metrics (TTM)
Gross Margin
64.28%
Operating Margin
8.51%
Net Income Margin
14.29%
Return on Equity
25.38%
Return on Capital
18.02%
Return on Assets
16.30%
Earnings Yield
6.46%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$269.20M
Shares Outstanding
79.64M
Volume
13.26K
Avg. Volume
826.51K
Financials (TTM)
Gross Profit
$83.83M
Operating Income
$11.10M
EBITDA
$21.40M
Operating Cash Flow
$4.37M
Capital Expenditure
-$321.00K
Free Cash Flow
$4.05M
Cash & ST Invst.
$66.55M
Total Debt
$2.58M
Niagen Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$31.47M
+3.3%
Gross Profit
$19.98M
+3.3%
Gross Margin
63.47%
N/A
Market Cap
$269.20M
N/A
Market Cap/Employee
$2.59M
N/A
Employees
104
N/A
Net Income
$6.32M
+24.8%
EBITDA
$7.03M
+25.5%
Quarterly Fundamentals
Total Cash
$66.55M
+20.0%
Total Debt
$2.58M
-26.9%
Accounts Receivable
$13.07M
+85.3%
Inventory
$24.02M
+114.7%
Long Term Debt
$1.54M
-40.1%
Short Term Debt
$1.03M
+8.9%
Return on Assets
16.30%
N/A
Return on Invested Capital
12.13%
N/A
Free Cash Flow
-$1.26M
-116.0%
Operating Cash Flow
-$1.19M
-115.1%